Clinical Trial Update: The Effects of Alendronate After Cure of Primary Hyperparathyroidism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of alendronate after cure of primary hyperparathyroidism has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Columbia University | Conditions: Hyperparathyroidism | Phase 4 | Status: WITHDRAWN